Biotech · Private company · Boulder, CO, US
Bolder Biotechnology, Inc.
Track this companyFree. Adds Bolder Biotechnology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Improving survival from Burkholderia pseudomallei and other pathogenic intracellular bacteriaFiscal year 2024 · $295.9KNIH RePORTER 1R43AI181293-01 · fetched Nov 12, 2026
- Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiationFiscal year 2024 · $717.4KNIH RePORTER 5R44AI142909-04 · fetched Nov 12, 2026
- ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"Fiscal year 2024 · $1.4MNIH RePORTER 75N93023C00011-P00002-9999-1 · fetched Nov 12, 2026